Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS
文献类型：期刊论文
| 作者 | Hu, Wenjuan1 ; Chang, Lu1; Ke, Changqiang1; Xie, Yuanchao1; Shen, Jingshan1; Tan, Bo2; Liu, Jia1
|
| 刊名 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
 |
| 出版日期 | 2021-02-05 |
| 卷号 | 194页码:10 |
| 关键词 | Remdesivir Nucleotide monophosphate Nucleotide triphosphate Stability Recovery LC-MS/MS |
| ISSN号 | 0731-7085 |
| DOI | 10.1016/j.jpba.2020.113806 |
| 通讯作者 | Tan, Bo(tbot@163.com) ; Liu, Jia(jia.liu@simm.ac.cn) |
| 英文摘要 | Remdesivir is a prodrug of the nucleotide analogue and used for COVID-19 treatment. However, the bioanalysis of the active metabolites remdesivir nucleotide triphosphate (RTP) and its precursor remdesivir nucleotide monophosphate (RMP) is very challenging. Herein, we established a novel method to separate RTP and RMP on a BioBasic AX column and quantified them by high-performance liquid chromatography-tandem mass spectrometry in positive electrospray ionization mode. Stepwise, we optimized chromatographic retention on an anion exchange column, improved stability in matrix through the addition of 5,5'-dithiobis-(2nitrobenzoic acid) and PhosSTOP EASYpack, and increased recovery by dissociation of tight protein binding with 2 % formic acid aqueous solution. The method allowed lower limit of quantification of 20 nM for RMP and 10 nM for RTP. Method validation demonstrated acceptable accuracy (93.6%-103% for RMP, 94.5%-107% for RTP) and precision (RSD < 11.9 % for RMP, RSD < 11.4 % for RTP), suggesting that it was sensitive and robust for simultaneous quantification of RMP and RTP. The method was successfully applied to analyze RMP and RTP in mouse tissues. In general, the developed method is suitable to monitor RMP and RTP, and provides a useful approach for exploring more detailed effects of remdesivir in treating diseases. (C) 2020 Elsevier B.V. All rights reserved. |
| WOS关键词 | CLOFARABINE TRIPHOSPHATE ; MASS-SPECTROMETRY ; QUANTIFICATION ; MONO |
| 资助项目 | Youth Innovation Promotion Association of the Chinese Academy of Sciences[2016263] ; Shanghai Shuguang Hospital[SGXZ-201907] |
| WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000605512600050 |
| 出版者 | ELSEVIER |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/295927]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Tan, Bo; Liu, Jia |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Shanghai Univ Tradit Chinese Med, Clin Pharmacokinet Lab, Shuguang Hosp, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Hu, Wenjuan,Chang, Lu,Ke, Changqiang,et al. Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS[J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,2021,194:10. |
| APA | Hu, Wenjuan.,Chang, Lu.,Ke, Changqiang.,Xie, Yuanchao.,Shen, Jingshan.,...&Liu, Jia.(2021).Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,194,10. |
| MLA | Hu, Wenjuan,et al."Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS".JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 194(2021):10. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。